Arcellx (ACLX) Tax Provisions (2023 - 2025)
Arcellx's (ACLX) quarterly Tax Provisions came in at -$48000.0 in Q4 2025, down 103.27% year-on-year from $1.5 million in Q4 2024, and down 265.52% quarter-over-quarter from $29000.0 in Q2 2025.
Arcellx (ACLX) Tax Provisions (2023 - 2025) Analysis & Trends
Arcellx's Tax Provisions history runs 3 years deep, the most recent figure standing at -$48000.0 for Q4 2025.
- On a quarterly basis, Tax Provisions fell 103.27% year-over-year to -$48000.0 in Q4 2025; TTM through Dec 2025 was -$19000.0, a 100.95% decrease from a year earlier, with the FY2025 full-year figure at -$19000.0, down 100.92% from the prior year.
- Tax Provisions declined to -$48000.0 in Q4 2025 per ACLX's latest filing, from $29000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $1.5 million in Q4 2024 and bottomed at -$300000.0 in Q2 2023.
- The 3-year median for Tax Provisions is $223000.0 (2024), against an average of $290888.9.
- Across the five-year window, Tax Provisions surged 3816.67% in 2024 and slumped 103.27% in 2025, its largest moves.
- Year by year, Tax Provisions stood at $622000.0 in 2023, then surged by 136.17% to $1.5 million in 2024, then plunged by 103.27% to -$48000.0 in 2025.
- Per Business Quant, the three latest ACLX Tax Provisions figures stand at -$48000.0 (Q4 2025), $29000.0 (Q2 2025), and $1.5 million (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | -48,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -48,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Dec 31, 2024 | 1.47 Mn |
| Sep 30, 2024 | 223,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Dec 31, 2023 | 622,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Jun 30, 2023 | -300,000.00 |
| Mar 31, 2023 | 329,000.00 |